Financhill
Back

CytoSorbents Quote, Financials, Valuation and Earnings

CytoSorbents Price Quote

$0.90
-0.01 (2.28%)
(Updated: December 21, 2024 at 5:21 AM ET)

CytoSorbents Key Stats

Sell
29
CytoSorbents (CTSO) is a Sell

Day range:
$0.86 - $0.92
52-week range:
$0.70 - $1.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.42
P/B ratio:
3.85%

Volume:
160.2K
Avg. volume:
160K
1-year change:
-50.48%
Market cap:
$50.1M
Revenue:
$31.1M
EPS:
$-0.36

How Much Does CytoSorbents Make?

Data Unavailable

Is CytoSorbents Growing As A Company?

Data Unavailable

CytoSorbents Stock Price Performance

  • Did CytoSorbents Stock Go Up Last Month?
    CytoSorbents share price went down by -0.51% last month
  • Did CTSO's Share Price Rise Over The Last Year?
    CTSO share price fell by -50.48% over the past 1 year

What Is CytoSorbents 52-Week High & Low?

CytoSorbents Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CytoSorbents?

Data Unavailable

Is CytoSorbents Cash Flow Positive?

Data Unavailable

CytoSorbents Return On Invested Capital

Data Unavailable

CytoSorbents Earnings Date & Stock Price

  • What Is CytoSorbents's Stock Price Today?
    A single share of CTSO can be purchased today for 0.91
  • What Is CytoSorbents’s Stock Symbol?
    CytoSorbents trades on the nasdaq under the ticker symbol: CTSO
  • When Is CytoSorbents’s Next Earnings Date?
    The next quarterly earnings date for CytoSorbents is scheduled on March 14, 2025
  • When Is CTSO's next ex-dividend date?
    CytoSorbents's next ex-dividend date is December 22, 2024
  • How To Buy CytoSorbents Stock?
    You can buy CytoSorbents shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CytoSorbents Competitors

  • Who Are CytoSorbents's Competitors?
    Below is a list of companies who compete with CytoSorbents or are related in some way:
    • Delcath Systems Inc (DCTH)
    • Exact Sciences Corp (EXAS)
    • Illumina Inc (ILMN)
    • Progyny Inc (PGNY)
    • Star Equity Holdings Inc (STRR)

CytoSorbents Dividend Yield

Data Unavailable

CytoSorbents Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.32%
Revenue: 11.08% -7.72%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable